IDEAYA Biosciences Q2 2024 GAAP EPS $(0.68) Misses $(0.54) Estimate
Portfolio Pulse from Benzinga Newsdesk
IDEAYA Biosciences reported a Q2 2024 GAAP EPS of $(0.68), missing the estimated $(0.54).
August 06, 2024 | 10:05 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
IDEAYA Biosciences reported a Q2 2024 GAAP EPS of $(0.68), which is worse than the estimated $(0.54). This earnings miss could negatively impact the stock price in the short term.
The earnings miss indicates that the company's financial performance was worse than expected, which typically leads to a negative reaction from investors and a potential drop in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100